Cargando…
A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293251/ https://www.ncbi.nlm.nih.gov/pubmed/37365170 http://dx.doi.org/10.1038/s41408-023-00876-w |
| _version_ | 1785062960517873664 |
|---|---|
| author | Johnson, Steven M. Haberberger, James Galeotti, Jonathan Ramkissoon, Lori Coombs, Catherine C. Richardson, Daniel R. Foster, Matthew C. Duncan, Daniel Zeidner, Joshua F. Ferguson, Naomi L. Montgomery, Nathan D. |
| author_facet | Johnson, Steven M. Haberberger, James Galeotti, Jonathan Ramkissoon, Lori Coombs, Catherine C. Richardson, Daniel R. Foster, Matthew C. Duncan, Daniel Zeidner, Joshua F. Ferguson, Naomi L. Montgomery, Nathan D. |
| author_sort | Johnson, Steven M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10293251 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102932512023-06-28 A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease Johnson, Steven M. Haberberger, James Galeotti, Jonathan Ramkissoon, Lori Coombs, Catherine C. Richardson, Daniel R. Foster, Matthew C. Duncan, Daniel Zeidner, Joshua F. Ferguson, Naomi L. Montgomery, Nathan D. Blood Cancer J Correspondence Nature Publishing Group UK 2023-06-26 /pmc/articles/PMC10293251/ /pubmed/37365170 http://dx.doi.org/10.1038/s41408-023-00876-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Johnson, Steven M. Haberberger, James Galeotti, Jonathan Ramkissoon, Lori Coombs, Catherine C. Richardson, Daniel R. Foster, Matthew C. Duncan, Daniel Zeidner, Joshua F. Ferguson, Naomi L. Montgomery, Nathan D. A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease |
| title | A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease |
| title_full | A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease |
| title_fullStr | A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease |
| title_full_unstemmed | A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease |
| title_short | A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease |
| title_sort | reappraisal of asxl1 mutation sites and the cohesin-binding motif in myeloid disease |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293251/ https://www.ncbi.nlm.nih.gov/pubmed/37365170 http://dx.doi.org/10.1038/s41408-023-00876-w |
| work_keys_str_mv | AT johnsonstevenm areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT haberbergerjames areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT galeottijonathan areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT ramkissoonlori areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT coombscatherinec areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT richardsondanielr areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT fostermatthewc areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT duncandaniel areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT zeidnerjoshuaf areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT fergusonnaomil areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT montgomerynathand areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT johnsonstevenm reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT haberbergerjames reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT galeottijonathan reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT ramkissoonlori reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT coombscatherinec reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT richardsondanielr reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT fostermatthewc reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT duncandaniel reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT zeidnerjoshuaf reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT fergusonnaomil reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease AT montgomerynathand reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease |